TP003/#1538 Phase 3 ENGOT-en23/GOG-3095/MK-2870–005 study: sacituzumab tirumotecan (Sac-TMT) monotherapy vs treatment of physician’s choice chemotherapy in patients with endometrial cancer who received prior chemotherapy and immunotherapy
作者
Domenica Lorusso,Toon Van Gorp,Flora Zagouri,Lubomir Bodnar,Dearbhaile Catherine Collins,Jacob Korach,Christian Marth,Judith R. Kroep,Jianqing Zhu,Kosei Hasegawa,Vanessa Samouëlian,Jung‐Yun Lee,Fernanda Cano Casarotto,Yoland Catherine Antill,Dana M. Chase,Mark S. Shahin,Robert J. Orlowski,Kristina Demas Woodhouse,Yi Wen Cui,Lyndsay J. Willmott